FDA Guidance for Industry: "Lookback" for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV

Titel:

Internet:

http://www.gmp-compliance.org/guidemgr/files/HCVLKBK.PDF

Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/

Dokumentenart:

Guidance for Industry DRAFT

Inhalt:

Compliance mit 21 CFR 610.47 and 21 CFR 610.48 to (1) für Blutspendezentren und Hospitler bzgl. HCV

Zurück

FDA Guidance for Industry: "Lookback" for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV

GMP Seminare nach Thema